TEMPE, Ariz., Feb. 9, 2026 /PRNewswire/ -- Nootropics Depot, a Tempe-based manufacturer and retailer of nootropics and dietary supplements, is highlighting its pharmaceutical-grade analytical and research facilities as part of an ongoing initiative to raise transparency and quality standards across the supplement industry. The company operates multiple laboratories and production buildings equipped with advanced analytical instrumentation and live-cell research capabilities typically associated with pharmaceutical development rather than conventional supplement manufacturing.

Walking through the Tempe complex, visitors encounter an integrated operation that controls every step from raw material verification through final product testing, rather than relying solely on contract manufacturers or supplier documentation. The analytical lab houses multiple UPLC and HPLC systems, alongside a preparative HPLC platform and supercritical fluid chromatography extraction technology used to isolate and quantify individual bioactive compounds from complex botanical ingredients. These capabilities support ingredient development and allow the team to confirm that products contain the specific compounds and potencies listed on their labels.

In addition to small-molecule analytics, Nootropics Depot has established a cell culture research program that studies how supplements affect human cells in real time. Using an Incucyte SX5 live-cell analysis system, researchers monitor neuronal and intestinal cell lines for changes in growth, morphology, and response to oxidative stress and inflammatory triggers when exposed to various ingredients, including mushroom extracts such as Lion's Mane. Data from this program help guide formulation decisions for products like Erinamax, a Lion's Mane supplement standardized to erinacine A and designed to support nerve growth factor–related mechanisms.

As part of its commitment to method standardization, Nootropics Depot is working to prepare its internally developed analytical methods for submission to AOAC International so they can be publicly available and adopted more widely by the dietary supplement testing community. This effort aligns with broader initiatives to establish and validate robust methods for verifying dietary ingredient identity and label content, particularly in complex botanical and mushroom categories where suitable compendial methods have historically been limited.

The company's internal library maintains a catalog of commercially available competitor products that are periodically tested for compound-specific content. These analyses have identified repeated discrepancies between labeled claims and measured levels of key bioactives in categories such as turkesterone, Ecklonia cava, and tongkat ali, highlighting the limitations of identity-only botanical testing and the impact of practices such as reusing spent plant material after extraction. Nootropics Depot's development of new testing methods and authenticated reference materials, including a multi-year effort to establish a verified Ecklonia cava standard, is intended to help close these gaps.

"Our goal has always been simple: verify, don't assume," said Paul Eftang, CEO of Nootropics Depot. "By investing in pharmaceutical-grade analytics, live-cell research, and method development, we can demonstrate exactly what is in our ingredients and how they behave at the cellular level, which is what consumers and responsible brands should be able to expect from this industry."

Nootropics Depot is now making portions of its testing infrastructure available to other supplement companies through Omnient Labs, an affiliated analytical services provider. By opening access to compound-specific testing and validated methods, the company aims to support broader industry efforts to substantiate label claims and align quality practices more closely with regulatory expectations and scientific best practices.

About Nootropics Depot

Nootropics Depot is a leading supplement company setting benchmark standards for quality and transparency in the industry. Founded in 2013, Nootropics Depot's mission has been to educate consumers on the science behind dietary supplements, and to advance the lab testing and quality control standards of the industry. Their stance is that consumers should be able to trust the products they buy, and that the brands selling those products have a duty to ensure they are using modern validated science. Nootropics Depot offers a wide range of high-quality cognitive enhancement and general health supplements. The company's commitment to quality and transparency is evident in their rigorous testing procedures, easily accessible Certificates of Analysis (COAs), and lab testing results available on every product page. In addition, they have formed a Scientific Advisory Board with board certified doctors, PhD researchers, and botanists to ensure that consumers can trust that scientific rigor is being upheld in everything they do. Nootropics Depot's newly redesigned website features a user-friendly interface, and includes an innovative quiz to help beginners find the right supplements for their needs. With partnerships with third-party labs, and collaboration with the Future Nutra Foundation, Nootropics Depot continues to push the boundaries of supplement quality and consumer education. For more information about Nootropics Depot's products and their commitment to transparency, visit nootropicsdepot.com.

Media Contact:
Michael Packman
Marketing Manager
Nootropics Depot
mpackman@nootropicsdepot.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nootropics-depot-showcases-pharmaceutical-grade-supplement-testing-labs-302682717.html

SOURCE Nootropics Depot